Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8833899 | Journal of the American College of Surgeons | 2017 | 6 Pages |
Abstract
The overall risk of upgrade of FEA to malignancy is low at 2.4%; however, the upgrade rate to a higher-risk lesion is nearly 30%. Surveillance rather than surgical excision of FEA can be a reasonable option for patients without a genetic mutation who opt against chemoprevention.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Leslie R. MD, MSc, Manisha MD, MPH, Michele A. MD, FACS, Constance D. MD, PhD,